These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25745361)

  • 21. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
    PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.
    Huang H; Lee MH; Liu K; Dong Z; Ryoo Z; Kim MO
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
    Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
    Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
    Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.
    Ayllón V; O'connor R
    Oncogene; 2007 May; 26(24):3451-61. PubMed ID: 17160018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.
    Lee DH; Jeong YJ; Won JY; Sim HI; Park Y; Jin HS
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.
    Mi W; Lin Q; Childress C; Sudol M; Robishaw J; Berlot CH; Shabahang M; Yang W
    Oncogene; 2015 Jun; 34(24):3095-106. PubMed ID: 25109332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geranylgeranylation signaling promotes breast cancer cell mitosis via the YAP-activated transcription of kinetochore/centromere genes.
    Wei J; Xia S; Sun A; Qu Y; Gao J; Shao G; Yang W; Lin Q
    Am J Cancer Res; 2022; 12(3):1143-1155. PubMed ID: 35411228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Protective Role of the TOPK/PBK Pathway in Myocardial Ischemia/Reperfusion and H₂O₂-Induced Injury in H9C2 Cardiomyocytes.
    Sun G; Ye N; Dai D; Chen Y; Li C; Sun Y
    Int J Mol Sci; 2016 Feb; 17(3):267. PubMed ID: 26907268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
    Wang MY; Lin ZR; Cao Y; Zheng LS; Peng LX; Sun R; Meng DF; Xie P; Yang JP; Cao L; Xu L; Huang BJ; Qian CN
    Oncotarget; 2016 May; 7(18):26604-16. PubMed ID: 27049917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase.
    Yang J; Yuan D; Xing T; Su H; Zhang S; Wen J; Bai Q; Dang D
    J Ginseng Res; 2016 Oct; 40(4):400-408. PubMed ID: 27746693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase.
    Zou J; Kuang W; Hu J; Rao H
    Biochem Biophys Res Commun; 2017 Jun; 488(2):247-252. PubMed ID: 28373071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
    Deng M; Yang R; Sun Q; Zhang J; Miao J
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
    Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
    Gao T; Hu Q; Hu X; Lei Q; Feng Z; Yu X; Peng C; Song X; He H; Xu Y; Zuo W; Zeng J; Liu Z; Yu L
    Cancer Lett; 2019 Mar; 445():11-23. PubMed ID: 30590102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of T-lymphokine-activated killer cell-originated protein kinase for TRAIL resistance of human HeLa cervical cancer cells.
    Kwon HR; Lee KW; Dong Z; Lee KB; Oh SM
    Biochem Biophys Res Commun; 2010 Jan; 391(1):830-4. PubMed ID: 19945431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of TOPK/PBK in children with malignant lymphoma or reactive lymphoid hyperplasia].
    Tian X; He XL; Yuan XY; Zou RY; Zou H; You YL; Chen KK; Zhu CG
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Mar; 20(3):214-217. PubMed ID: 29530122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.
    Brown-Clay JD; Shenoy DN; Timofeeva O; Kallakury BV; Nandi AK; Banerjee PP
    Oncotarget; 2015 Jun; 6(17):15594-609. PubMed ID: 25909225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
    Shahab SW; Roggeveen CM; Sun J; Kunhiraman H; McSwain LF; Juraschka K; Kumar SA; Saulnier O; Taylor MD; Schniederjan M; Schnepp RW; MacDonald TJ; Kenney AM
    Mol Oncol; 2023 Sep; 17(9):1784-1802. PubMed ID: 37341142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo-YAP/TAZ pathway mediates geranylgeranylation signaling in breast cancer progression.
    Lin Q; Yang W
    Mol Cell Oncol; 2016 May; 3(3):e969638. PubMed ID: 27314103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.